Phamaceutical Composition Comprising an Extract of Artemisia scoparia for Preventing or Treating Metabolic Bone Disease-induced Bone Loss

摘要

The present invention relates to a pharmaceutical composition for preventing or treating bone loss induced by bone metabolic diseases, comprising an extract of mugwort mugwort as an active ingredient. Mugwort extract shows the efficacy of preventing or treating bone loss induced by bone metabolic diseases by inhibiting the differentiation of osteoclasts and the activity of NFATc1. For the prevention or improvement of bone loss induced by bone metabolic diseases or a pharmaceutical composition for preventing or treating bone loss induced by bone metabolic diseases that can be safely used in the human body without toxicity and side effects when using the extract of the present invention due to the above efficacy A food composition may be provided.